Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736

Andrew S. Moore(University of Queensland), Spiros Linardopoulos(Institute of Cancer Research)
Blood Advances
April 13, 2020
Cited by 26


Related Papers